Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 16 de 16
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
FEBS Lett ; 587(10): 1579-86, 2013 May 21.
Artigo em Inglês | MEDLINE | ID: mdl-23587483

RESUMO

Both radiotherapy and most effective chemotherapeutic agents induce different types of DNA damage. Here we show that tungstate modulates cell response to DNA damaging agents. Cells treated with tungstate were more sensitive to etoposide, phleomycin and ionizing radiation (IR), all of which induce DNA double-strand breaks (DSBs). Tungstate also modulated the activation of the central DSB signalling kinase, ATM, in response to these agents. These effects required the functionality of the Mre11-Nbs1-Rad50 (MRN) complex and were mimicked by the inhibition of PP2A phosphatase. Therefore, tungstate may have adjuvant activity when combined with DNA-damaging agents in the treatment of several malignancies.


Assuntos
Proteínas de Ciclo Celular/fisiologia , Dano ao DNA/efeitos dos fármacos , Proteínas de Ligação a DNA/fisiologia , Proteínas Serina-Treonina Quinases/fisiologia , Proteínas Supressoras de Tumor/fisiologia , Compostos de Tungstênio/farmacologia , Animais , Proteínas Mutadas de Ataxia Telangiectasia , Proteínas de Ciclo Celular/metabolismo , Proliferação de Células/efeitos dos fármacos , Células Cultivadas , Quebras de DNA de Cadeia Dupla/efeitos dos fármacos , Quebras de DNA de Cadeia Dupla/efeitos da radiação , Dano ao DNA/genética , Proteínas de Ligação a DNA/metabolismo , Relação Dose-Resposta a Droga , Avaliação Pré-Clínica de Medicamentos , Células HEK293 , Células HeLa , Humanos , Camundongos , Proteínas Serina-Treonina Quinases/metabolismo , Doses de Radiação , Radiação Ionizante , Transdução de Sinais/efeitos dos fármacos , Transdução de Sinais/genética , Transdução de Sinais/efeitos da radiação , Proteínas Supressoras de Tumor/metabolismo
2.
FEBS Lett ; 586(3): 270-6, 2012 Feb 03.
Artigo em Inglês | MEDLINE | ID: mdl-22245679

RESUMO

Tungstate counteracts diabetes and obesity in animal models, but its molecular mechanisms remain elusive. Our Saccharomyces cerevisiae-based approach has found that tungstate alleviated the growth defect induced by nutrient stress and enhanced the activation of the GCN pathway. Tungstate relieved the sensitivity to starvation of a gcn2-507 yeast hypomorphic mutant, indicating that tungstate modulated the GCN pathway downstream of Gcn2p. Interestingly, tungstate inhibited Glc7p and PP1 phosphatase activity, both negative regulators of the GCN pathway in yeast and humans, respectively. Accordingly, overexpression of a dominant-negative Glc7p mutant in yeast mimicked tungstate effects. Therefore tungstate alleviates nutrient stress in yeast by in vivo inhibition of Glc7p. These data uncover a potential role for tungstate in the treatment of PP1 and GCN related diseases.


Assuntos
Fármacos Antiobesidade/farmacologia , Antineoplásicos/farmacologia , Hipoglicemiantes/farmacologia , Proteína Fosfatase 1/antagonistas & inibidores , Proteínas de Saccharomyces cerevisiae/antagonistas & inibidores , Saccharomyces cerevisiae/efeitos dos fármacos , Saccharomyces cerevisiae/metabolismo , Compostos de Tungstênio/farmacologia , Aminoácidos/deficiência , Sinergismo Farmacológico , Alimentos , Humanos , Mutação , Proteínas Serina-Treonina Quinases/genética , Saccharomyces cerevisiae/genética , Saccharomyces cerevisiae/crescimento & desenvolvimento , Proteínas de Saccharomyces cerevisiae/genética , Tacrolimo/farmacologia , Triazóis/química , Triazóis/farmacologia
3.
Cancer Lett ; 273(2): 281-91, 2009 Jan 18.
Artigo em Inglês | MEDLINE | ID: mdl-18818012

RESUMO

Radio and chemotherapy are the election options besides surgical resection, in cancer treatment. However, resistance to chemotherapy limits the effectiveness of therapy in the clinic. An improved knowledge of the mechanisms underlying the resistance to treatment would generate new therapeutic strategies. Genetic suppressor elements (GSEs) are short, biologically active, cDNA fragments that interfere with the function of their cognate gene. By selection of genetic suppressor elements (GSEs) conferring resistance to cisplatin, we identified the GSE11, that corresponds to the hCCR4/CNOT6 gene that mediates cellular sensitivity to the drug. Expression of GSE11-hCCR4 reduces hCCR4 protein levels in cells. Targeting hCCR4 with GSE11 or with siRNA, decreases sensitivity of mammalian cells to DNA-damaging agents. Overexpression of hCCR4 targets Chk2 following exposure to cisplatin, without interfering with the upstream ATM/ATR pathway, however histone gammaH2AX is strongly phosphorylated in these cells compared to control cells. Our results uncover a new function for a human protein involved in chemotherapy response. This finding introduces a new pharmacological target in the treatment of solid tumours.


Assuntos
Dano ao DNA , Exorribonucleases/metabolismo , Histonas/genética , Animais , Antineoplásicos/farmacologia , Sobrevivência Celular , Cisplatino/farmacologia , Exorribonucleases/genética , Biblioteca Gênica , Humanos , Camundongos , Microscopia de Fluorescência , Fosforilação , RNA Interferente Pequeno/metabolismo , Elementos de Resposta
4.
Clin Transl Oncol ; 9(4): 221-8, 2007 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-17462974

RESUMO

The budding yeast Saccharomyces cerevisiae is being widely used as a model for investigating fundamental processes relevant to all living organisms. Many of these processes are affected by genetic and epigenetic alterations in cancer such as cell cycle progression, DNA replication and segregation, maintenance of genomic integrity and stress responses. Therefore, yeast emerges as an attractive model for anticancer drug research. The genetic tractability of budding yeast, its ease of manipulation and the wealth of functional genomics tools available in this organism makes it ideal for genome-wide analysis of biological functions and chemical screenings. The present review will discuss some of the innovative advantages based on yeast genetics and genomics for antitumour drug target identification and drug discovery.


Assuntos
Antineoplásicos , Desenho de Fármacos , Ensaios de Seleção de Medicamentos Antitumorais/métodos , Saccharomyces cerevisiae/efeitos dos fármacos , Saccharomyces cerevisiae/genética , Antineoplásicos/farmacologia , DNA Complementar/genética , Farmacorresistência Fúngica , Deleção de Genes , Perfilação da Expressão Gênica , Regulação Fúngica da Expressão Gênica , Genes Fúngicos , Pesquisa em Genética , Genômica/métodos , Humanos , Mutação , Análise de Sequência com Séries de Oligonucleotídeos , Proteômica/métodos
5.
Clin. transl. oncol. (Print) ; 9(4): 221-228, abr. 2007. ilus
Artigo em Inglês | IBECS | ID: ibc-123296

RESUMO

The budding yeast Saccharomyces cerevisiae is being widely used as a model for investigating fundamental processes relevant to all living organisms. Many of these processes are affected by genetic and epigenetic alterations in cancer such as cell cycle progression, DNA replication and segregation, maintenance of genomic integrity and stress responses. Therefore, yeast emerges as an attractive model for anticancer drug research. The genetic tractability of budding yeast, its ease of manipulation and the wealth of functional genomics tools available in this organism makes it ideal for genome-wide analysis of biological functions and chemical screenings. The present review will discuss some of the innovative advantages based on yeast genetics and genomics for antitumour drug target identification and drug discovery (AU)


Assuntos
Humanos , Masculino , Feminino , Antineoplásicos/farmacologia , Desenho de Fármacos , Ensaios de Seleção de Medicamentos Antitumorais/métodos , Ensaios de Seleção de Medicamentos Antitumorais , Saccharomyces cerevisiae , Saccharomyces cerevisiae/genética , DNA Complementar/genética , Farmacorresistência Fúngica , Análise de Sequência com Séries de Oligonucleotídeos/métodos , Proteômica/métodos
6.
Cell Mol Life Sci ; 61(6): 700-8, 2004 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-15052412

RESUMO

The immunosuppressants tacrolimus (FK506) and cyclosporin A (CsA) have increased the survival rates in organ transplantation. Both drugs inhibit the protein phosphatase calcineurin (CaN) in activated T cells, exhibiting similar side-effects. Diabetes is observed more often in FK506 than CsA therapy, probably due to inhibition of new molecular targets other than CaN. We studied FK506 toxicity in mammalian cells. FK506, but not CsA, regulated p38 activation by osmotic stress, and decreased viability in osmostressed cells. In addition, FK506 treatment strongly increased the phosphorylation of the eukaryotic initiation factor-2alpha (eIF-2alpha) subunit. eIF-2alpha phosphorylation, p38 inhibition and cell lethality were relieved by addition of excess amino acids to the medium, suggesting that amino acid availability mediated FK506 toxicity. Therefore, these FK506-dependent responses could be relevant to the non-therapeutic effects of FK506 therapy.


Assuntos
Imunossupressores/farmacologia , Rim/efeitos dos fármacos , Proteínas Quinases Ativadas por Mitógeno/metabolismo , Tacrolimo/farmacologia , Calcineurina/metabolismo , Calcineurina/farmacologia , Morte Celular/efeitos dos fármacos , Células Cultivadas , Ciclosporina/farmacologia , Ativação Enzimática , Fator de Iniciação 2 em Eucariotos/metabolismo , Humanos , Rim/citologia , Rim/enzimologia , Proteínas Quinases Ativadas por Mitógeno/antagonistas & inibidores , Concentração Osmolar , Fosforilação/efeitos dos fármacos , Saccharomyces cerevisiae , Proteínas de Saccharomyces cerevisiae/metabolismo , Transdução de Sinais/efeitos dos fármacos , Sorbitol/farmacologia , Triptofano/metabolismo , Proteínas Quinases p38 Ativadas por Mitógeno
7.
J Nat Prod ; 66(5): 722-4, 2003 May.
Artigo em Inglês | MEDLINE | ID: mdl-12762819

RESUMO

The aerial parts of Nanodea muscosa, collected in Chile, yielded two new acetylenic acids. Their structures were elucidated by spectroscopic analyses, including 2D NMR techniques, as (13E)-octadec-13-en-11-ynoic acid (1) and (2E)-octadec-2-en-4-ynedioic acid (2). Compound 2 constitutes the first example of a conjugated ene-yne fatty diacid isolated from a natural source. Compounds 1 and 2 did not exhibit toxicity toward a panel of DNA damage checkpoint defective yeast mutants or show affinity for the 5-HT(1A), 5-HT(2A), D(2), and H(1) receptors.


Assuntos
Ácidos Graxos Insaturados/isolamento & purificação , Santalaceae/química , Alcinos , Chile , Dano ao DNA/efeitos dos fármacos , Ácidos Graxos Insaturados/química , Ácidos Graxos Insaturados/farmacologia , Estrutura Molecular , Receptor 5-HT2A de Serotonina , Receptores de Dopamina D2/efeitos dos fármacos , Receptores Histamínicos H1/efeitos dos fármacos , Receptores de Serotonina/efeitos dos fármacos , Receptores 5-HT1 de Serotonina , Saccharomyces cerevisiae/efeitos dos fármacos , Estereoisomerismo
8.
Curr Opin Genet Dev ; 10(1): 17-25, 2000 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-10679395

RESUMO

DNA damage or stalled DNA replication can activate specific signal transduction pathways, termed checkpoints. Checkpoint activation can result in increased repair, induction of a transcriptional programme and inhibition of cell-cycle progression. Recent results have suggested possible mechanisms for the detection of specific DNA structures, provided further information on the organisation of the signal transduction cascade and demonstrated involvement of the checkpoint pathway in DNA repair.


Assuntos
Dano ao DNA , Genes cdc , Transdução de Sinais , Animais , Apoptose , Ciclo Celular , Dano ao DNA/genética , Dano ao DNA/fisiologia , Reparo do DNA , Humanos , Leveduras
9.
Genes Dev ; 12(16): 2560-73, 1998 Aug 15.
Artigo em Inglês | MEDLINE | ID: mdl-9716408

RESUMO

Preventing or delaying progress through the cell cycle in response to DNA damage is crucial for eukaryotic cells to allow the damage to be repaired and not incorporated irrevocably into daughter cells. Several genes involved in this process have been discovered in fission and budding yeast. Here, we report the identification of human and mouse homologs of the Schizosaccharomyces pombe DNA damage checkpoint control gene rad1(+) and its Saccharomyces cerevisiae homolog RAD17. The human gene HRAD1 is located on chromosome 5p13 and is most homologous to S. pombe rad1(+). This gene encodes a 382-amino-acid residue protein that is localized mainly in the nucleus and is expressed at high levels in proliferative tissues. This human gene significantly complements the sensitivity to UV light of a S. pombe strain mutated in rad1(+). Moreover, HRAD1 complements the checkpoint control defect of this strain after UV exposure. In addition to functioning in DNA repair checkpoints, S. cerevisiae RAD17 plays a role during meiosis to prevent progress through prophase I when recombination is interrupted. Consistent with a similar role in mammals, Rad1 protein is abundant in testis, and is associated with both synapsed and unsynapsed chromosomes during meiotic prophase I of spermatogenesis, with a staining pattern distinct from that of the recombination proteins Rad51 and Dmc1. Together, these data imply an important role for hRad1 both in the mitotic DNA damage checkpoint and in meiotic checkpoint mechanisms, and suggest that these events are highly conserved from yeast to humans.


Assuntos
Proteínas de Ligação a DNA , Exonucleases/fisiologia , Meiose/fisiologia , Sequência de Aminoácidos , Animais , Ciclo Celular/fisiologia , Proteínas de Ciclo Celular/química , Núcleo Celular/metabolismo , Mapeamento Cromossômico , Dano ao DNA , Reparo do DNA , Enzimas Reparadoras do DNA , Endonucleases/química , Proteínas Fúngicas/química , Expressão Gênica , Teste de Complementação Genética , Células HeLa , Humanos , Masculino , Meiose/genética , Camundongos , Dados de Sequência Molecular , Mutação , Proteínas Nucleares , Prófase , Ratos , Saccharomyces cerevisiae/química , Saccharomyces cerevisiae/citologia , Saccharomyces cerevisiae/genética , Proteínas de Saccharomyces cerevisiae , Schizosaccharomyces/química , Schizosaccharomyces/genética , Proteínas de Schizosaccharomyces pombe , Homologia de Sequência de Aminoácidos , Espermatogênese/genética , Espermatogênese/fisiologia , Testículo/citologia , Testículo/fisiologia , Regulação para Cima
10.
Oncogene ; 16(4): 533-40, 1998 Jan 29.
Artigo em Inglês | MEDLINE | ID: mdl-9484843

RESUMO

Genotoxic stress triggers signalling pathways that either mediate cell killing or protection of affected cells. While induction of p53 is observed for most of the genotoxins, activation of MAPK/SAPK cascades is not a general response. The role of MAPK/SAPK activation on cell fate, seems to be dependent, in some systems, on the balanced response among both cascades. We have here examined the effect of cis and trans-DDP on the activation of ERK and JNK activities. While no significant induction of ERK was observed with the compounds, both of them are able to strongly activate JNK. Trans-DDP response is rapid and transient while the cis-DDP one is slow and persistent. In contrast with the observed nuclear translocation of JNK in response to U.V. light, none of the platinum compounds induces translocation, on the contrary, activation of JNK occurs in both the nuclear and cytoplasmic compartments. Inhibition of tyrosine phosphatases by orthovanadate pretreatment prolongs the time of JNK induction in response to both platinum compounds. The positive modulation of JNK activation correlates with an increase in toxicity that, for cis-DDP corresponds to a tenfold decrease in the IC50. A strong increase in MKP-1 levels was observed only in response to trans-DDP suggesting the involvement of this activity in the downregulation of JNK activity in response to this compound. Altogether the results suggest that the prolonged activation of JNK in response to cis-DDP contributes to cell death induction.


Assuntos
Antineoplásicos/farmacologia , Apoptose , Proteínas Quinases Dependentes de Cálcio-Calmodulina/metabolismo , Cisplatino/farmacologia , Dano ao DNA , Proteínas Quinases Ativadas por Mitógeno , Animais , Linhagem Celular/efeitos dos fármacos , Linhagem Celular/enzimologia , Núcleo Celular/enzimologia , Citoplasma/enzimologia , Ativação Enzimática/efeitos dos fármacos , Proteínas Quinases JNK Ativadas por Mitógeno , Camundongos , Vanadatos/farmacologia
11.
J Biol Chem ; 271(46): 29029-33, 1996 Nov 15.
Artigo em Inglês | MEDLINE | ID: mdl-8910555

RESUMO

The yeast halotolerance gene HAL2 encodes a nucleotidase that dephosphorylates 3'-phosphoadenosine 5'-phosphate (PAP) and 3'-phosphoadenosine 5'-phosphosulfate (PAPS), intermediates of the sulfate assimilation pathway. This nucleotidase is inhibited by Na+ and Li+ but not by K+. Incubation of wild-type yeast cells with NaCl and LiCl, but not with KCl, increased intracellular PAP to millimolar concentrations. No depletion of the pool of adenine nucleotides (AMP, ADP, ATP) was observed. Other stresses such as heat shock or oxidative stress did not result in PAP accumulation. PAPS concentrations also increased during salt stress but remained lower than 0.5 microM. S-Adenosylmethionine concentrations decreased by 50%, reflecting inhibition of sulfate assimilation during salt stress. Salt-induced PAP accumulation was attenuated in a yeast strain overexpressing HAL2. This strain grew better than the wild type under salt stress. These results suggest that the cation sensitivity of the HAL2 nucleotidase is an important determinant of the inhibition of yeast growth by sodium and lithium salts. In addition to blocking sulfate assimilation by product inhibition of PAPS reductase, PAP accumulation may have other unidentified toxic effects.


Assuntos
Proteínas Fúngicas/metabolismo , Cloreto de Lítio/toxicidade , Nucleotidases/metabolismo , Cloreto de Lítio/metabolismo , Metionina/biossíntese , Saccharomyces cerevisiae/enzimologia , Saccharomyces cerevisiae/metabolismo , Especificidade por Substrato , Sulfatos/metabolismo
12.
J Cell Biochem ; 57(4): 630-40, 1995 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-7615647

RESUMO

Changes in intracellular pH (pHin) take part in the mitogenic response. Their importance has been stressed by the finding that mouse fibroblasts expressing a yeast proton pumping ATPase (PMA1) exhibit a transformed phenotype and are tumorigenic. These cells do maintain a higher pHin, supporting the idea that elevated pHin may act as a proliferative trigger. Here we show that cells constitutively expressing PMA1 have higher levels of the AP-1 transcription factor. The use of stable transfectants and transient transfection assays show that PMA1 activity induces transactivation of the c-fos promoter. The activation of the promoter is mediated throughout the serum response element (SRE). The use of protein kinase C inhibitors suggests that AP-1 activation is achieved through a pathway independent of protein kinase C.


Assuntos
Endopeptidases , Genes fos , Proteínas Oncogênicas , Regiões Promotoras Genéticas , Bombas de Próton/efeitos dos fármacos , Ativação Transcricional/efeitos dos fármacos , Células 3T3 , Adenosina Trifosfatases/biossíntese , Adenosina Trifosfatases/genética , Animais , Sequência de Bases , Bovinos , Colforsina/farmacologia , Meios de Cultura , Proteínas Quinases Dependentes de AMP Cíclico/metabolismo , Proteínas de Ligação a DNA/biossíntese , Proteínas de Ligação a DNA/genética , Eletroforese , Concentração de Íons de Hidrogênio , Camundongos , Dados de Sequência Molecular , Proteínas Nucleares/biossíntese , Proteínas Nucleares/genética , Proteínas de Fusão Oncogênica/biossíntese , Proteínas de Fusão Oncogênica/genética , Proteína Quinase C/metabolismo , Inibidores de Proteínas Quinases , Proteínas Proto-Oncogênicas , Fator de Resposta Sérica , Ativador de Plasminogênio Tecidual/farmacologia , Fator de Transcrição AP-1/biossíntese , Fator de Transcrição AP-1/genética , Fatores de Transcrição/biossíntese , Fatores de Transcrição/genética , Transfecção , Ubiquitina Tiolesterase
13.
J Gen Virol ; 76 ( Pt 4): 729-40, 1995 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-9049318

RESUMO

A group of cross-hybridizing DNA segments contained within the EcoRI restriction fragments U', X and J of a Vero cell-adapted strain (BA71V) of African swine fever virus (ASFV) were mapped and sequenced. Analysis of the nucleotide sequence revealed the presence of a set of long internal repeated sequences composed of five types of tandemly repeat units of about 200 bp. These tandem repeats contain a G-rich core of 10-14 nucleotides surrounded by regions with a high A + T content distributed in oligo(dA).oligo(dT) tracts. Next to the repeated sequences we detected two related open reading frames that are members of a new multigene family (multigene family 300). Comparison of DNA sequences from several virus isolates indicated that this region undergoes frequent rearrangements leading to either duplications or deletions of the repeat units. These ASFV repeated sequences share similarities with chromosomal alpha satellite DNA, the scaffold-associated region and satellite III of Drosophila. Similar tandemly repeated sequences have not been described in other viruses.


Assuntos
Vírus da Febre Suína Africana/genética , DNA Viral/análise , Sequências Repetitivas de Ácido Nucleico , Vírus da Febre Suína Africana/isolamento & purificação , Sequência de Aminoácidos , Animais , Sequência de Bases , Southern Blotting , Chlorocebus aethiops , Mapeamento Cromossômico , Desoxirribonuclease EcoRI/metabolismo , Desoxirribonuclease HindIII/metabolismo , Dados de Sequência Molecular , Fases de Leitura Aberta , Transcrição Gênica , Células Vero
14.
Science ; 267(5195): 232-4, 1995 Jan 13.
Artigo em Inglês | MEDLINE | ID: mdl-7809627

RESUMO

Overexpression of a yeast gene, HAL2, allows the cells to tolerate higher than normal extracellular salt concentrations. HAL2 encodes a 3'(2')5'-bisphosphate nucleotidase that serves to remove the end products of sulfate transfer during cellular metabolism. The enzyme is inhibited by lithium and sodium and is activated by potassium. Metabolic systems that are sensitive to salt, as well as those governing osmolyte synthesis and ion transport, offer routes by which genetic engineering can be used to improve the tolerance of various organisms to salt.


Assuntos
Proteínas Fúngicas/metabolismo , Lítio/farmacologia , Nucleotidases/metabolismo , Saccharomyces cerevisiae/enzimologia , Sódio/farmacologia , Sulfatos/metabolismo , Difosfato de Adenosina/metabolismo , Monofosfato de Adenosina/metabolismo , Ativação Enzimática , Proteínas Fúngicas/antagonistas & inibidores , Proteínas Fúngicas/genética , Nucleotidases/antagonistas & inibidores , Nucleotidases/genética , Potássio/farmacologia , Saccharomyces cerevisiae/efeitos dos fármacos , Saccharomyces cerevisiae/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...